Association between FNDC5 Deficiency and Compromised Mitochondrial Integrity and Biogenesis in Kidney Disease.

IF 3.7 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
International Journal of Medical Sciences Pub Date : 2026-09-03 eCollection Date: 2026-01-01 DOI:10.7150/ijms.130226
Chien-Wei Huang, Chia-Jung Li, Junne-Ming Sung, Yau-Sheng Tsai, Jin-Shuen Chen
{"title":"Association between FNDC5 Deficiency and Compromised Mitochondrial Integrity and Biogenesis in Kidney Disease.","authors":"Chien-Wei Huang, Chia-Jung Li, Junne-Ming Sung, Yau-Sheng Tsai, Jin-Shuen Chen","doi":"10.7150/ijms.130226","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mitochondrial dysfunction is a hallmark of acute and chronic kidney diseases. This study investigates the expression landscape and potential association of FNDC5 with renal injury.</p><p><strong>Methods: </strong>We integrated human scRNA-seq, mouse spatial transcriptomics (ischemia-reperfusion injury model), <i>in vitro</i> high-glucose (HG) models in proximal tubule cells and podocytes, and a constitutive <i>Fndc5</i> knockout mouse model. Candidate transcription factor occupancy at the FNDC5 promoter was examined by ChIP-qPCR, and associations were assessed in a non-insulin-dependent diabetes mellitus mouse model.</p><p><strong>Results: </strong>scRNA-seq localized <i>FNDC5</i> to specific tubules, showing downregulation in diabetic nephropathy. Spatial transcriptomics confirmed a distinct loss of cortical <i>Fndc5</i> following ischemia-reperfusion injury. <i>In vitro</i>, HG treatment suppressed FNDC5, reduced cell viability, and triggered mitochondrial fragmentation, evidenced by increased DRP1 phosphorylation and downregulated MFN1/OPA1. ZEB1 and CREB1 were identified as candidate transcription factors showing occupancy at the FNDC5 promoter. Genetic deletion of <i>Fndc5</i> reproduced this fission-permissive shift and reduced PGC1α expression under basal, non-diabetic conditions, providing loss-of-function evidence that <i>Fndc5</i> deficiency is sufficient to reproduce this phenotype, independent of any additional metabolic stressor. <i>In vivo</i>, diabetic mice exhibited diminished FNDC5 levels, which correlated with an oxidative stress-associated marker (4-HNE) and reduced expression of the biogenesis-associated marker PGC1α.</p><p><strong>Conclusion: </strong>FNDC5 downregulation is a conserved feature of renal injury associated with mitochondrial fission, and genetic loss-of-function data indicates that Fndc5 deficiency is sufficient to reproduce selected features of this fission-permissive mitochondrial phenotype; whether FNDC5 acts through a defined downstream pathway remains to be established.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 10","pages":"3281-3295"},"PeriodicalIF":3.7000,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617500/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/ijms.130226","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mitochondrial dysfunction is a hallmark of acute and chronic kidney diseases. This study investigates the expression landscape and potential association of FNDC5 with renal injury.

Methods: We integrated human scRNA-seq, mouse spatial transcriptomics (ischemia-reperfusion injury model), in vitro high-glucose (HG) models in proximal tubule cells and podocytes, and a constitutive Fndc5 knockout mouse model. Candidate transcription factor occupancy at the FNDC5 promoter was examined by ChIP-qPCR, and associations were assessed in a non-insulin-dependent diabetes mellitus mouse model.

Results: scRNA-seq localized FNDC5 to specific tubules, showing downregulation in diabetic nephropathy. Spatial transcriptomics confirmed a distinct loss of cortical Fndc5 following ischemia-reperfusion injury. In vitro, HG treatment suppressed FNDC5, reduced cell viability, and triggered mitochondrial fragmentation, evidenced by increased DRP1 phosphorylation and downregulated MFN1/OPA1. ZEB1 and CREB1 were identified as candidate transcription factors showing occupancy at the FNDC5 promoter. Genetic deletion of Fndc5 reproduced this fission-permissive shift and reduced PGC1α expression under basal, non-diabetic conditions, providing loss-of-function evidence that Fndc5 deficiency is sufficient to reproduce this phenotype, independent of any additional metabolic stressor. In vivo, diabetic mice exhibited diminished FNDC5 levels, which correlated with an oxidative stress-associated marker (4-HNE) and reduced expression of the biogenesis-associated marker PGC1α.

Conclusion: FNDC5 downregulation is a conserved feature of renal injury associated with mitochondrial fission, and genetic loss-of-function data indicates that Fndc5 deficiency is sufficient to reproduce selected features of this fission-permissive mitochondrial phenotype; whether FNDC5 acts through a defined downstream pathway remains to be established.

肾脏疾病中FNDC5缺乏与线粒体完整性受损和生物发生的关系
背景:线粒体功能障碍是急性和慢性肾脏疾病的标志。本研究探讨FNDC5的表达格局及其与肾损伤的潜在关联。方法:我们整合了人scRNA-seq,小鼠空间转录组学(缺血-再灌注损伤模型),近端小管细胞和足细胞的体外高糖(HG)模型,以及Fndc5基因敲除小鼠模型。通过ChIP-qPCR检测FNDC5启动子上候选转录因子的占用情况,并在非胰岛素依赖型糖尿病小鼠模型中评估其相关性。结果:scRNA-seq将FNDC5定位到特定的小管,在糖尿病肾病中显示下调。空间转录组学证实了缺血再灌注损伤后皮质Fndc5的明显缺失。在体外,HG处理抑制了FNDC5,降低了细胞活力,并引发了线粒体断裂,这可以通过DRP1磷酸化增加和MFN1/OPA1下调来证明。ZEB1和CREB1被确定为FNDC5启动子上的候选转录因子。在基础、非糖尿病条件下,Fndc5基因缺失再现了这种允许分裂的转变,并降低了PGC1α的表达,这提供了功能丧失的证据,证明Fndc5缺陷足以再现这种表型,独立于任何额外的代谢应激源。在体内,糖尿病小鼠表现出FNDC5水平降低,这与氧化应激相关标记物(4-HNE)和生物发生相关标记物PGC1α的表达降低有关。结论:FNDC5下调是与线粒体分裂相关的肾损伤的保守特征,基因功能丧失数据表明,FNDC5缺乏足以重现这种允许分裂的线粒体表型的选择特征;FNDC5是否通过确定的下游通路起作用仍有待确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Medical Sciences
International Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
7.20
自引率
0.00%
发文量
185
审稿时长
2.7 months
期刊介绍: Original research papers, reviews, and short research communications in any medical related area can be submitted to the Journal on the understanding that the work has not been published previously in whole or part and is not under consideration for publication elsewhere. Manuscripts in basic science and clinical medicine are both considered. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Short research communication is limited to be under 2500 words.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书